marijuana

Marijuana is currently illegal under federal law, but it is legal for medical and recreational use in a growing number of states. There is a growing body of research suggesting cannabis can be an effective treatment for a variety of medical conditions, including chronic pain, nausea, and seizures.

However, there are also some potential risks associated with marijuana use, including impaired driving, psychosis, and addiction. Here, STAT covers the scientific, legal, and political issues related to cannabis, CBD and medical marijuana.

All Coverage

First Opinion Jordan Tishler

STAT Plus: Pharmalittle: Trump administration pushes for international drug pricing index; is Roche starting a price war in cancer drugs?

First Opinion Beatriz H. Carlini, Gregory Carter and Nephi Stella

Most Read

Does smoking pot actually make you stupid?

States need to wake up to public health risks from cannabis

Medical cannabis unlikely to benefit most chronic pain patients, international researchers say

Enrollment in medical cannabis programs saw four-fold increase, study finds

This is your brain on pot: Neuroscientist studies long-term effects of medical marijuana

I wanted to try medical marijuana. Why couldn’t my doctors help me?

INTERACTIVE: Explore how illegal drugs have become cheaper and more potent over time

STAT Plus: Hair testing for drug use gains traction — but critics say the science needs to catch up

All Coverage

Cannabis legalization must address medical use, not just recreational use

Lessons about marijuana edibles from youth vaping

Decriminalization could help ease the nation’s drug epidemic, but the devil is in the details

STAT Plus: The FDA is finalizing its long-awaited rules for CBD

STAT Plus: DEA proposes new rule to approve new suppliers of marijuana for research

STAT Plus: Congress asked the FDA to explain its rules on CBD — but its new report offers little clarity

Cannabis use among older adults is on the rise, study says

Cash from cannabis companies creates conflicted researchers

The cannabis boom could be good for science — and scientists

One in five high school seniors vaped marijuana in the last year, fueling concern among health officials

STAT Plus: The company behind the first-ever CBD-based drug is now eyeing everything from multiple sclerosis to autism

STAT Plus: These four companies are betting big on CBD-based prescription drugs

Surgeon general: Marijuana during pregnancy and adolescence is dangerous

STAT Plus: Pharmalittle: Trump administration pushes for international drug pricing index; is Roche starting a price war in cancer drugs?

Cannabidiol confusion: lofty promises and barriers to research

STAT Plus: CBD is all the rage among patients. It’s launching their physicians into uncharted territory

Marijuana use doubles in U.S. pregnant women to 1 in 14

STAT Plus: At first-ever public hearing on CBD, advocates and FDA try to blaze trail to regulatory compromise

Access to medical cannabis: a new health care disparity

Scott Gottlieb is skeptical of the science behind CBD supplements

STAT Plus: Dude, where’s my regulatory framework? As CBD gains popularity, Washington struggles to keep up

STAT Plus: Harvard, MIT share $9 million gift to study marijuana’s health effects

Canada’s legalization of marijuana offers a blueprint for the U.S.

STAT Plus: As record number of states vote on marijuana, public health questions remain

Colorado gives marijuana candy a new look to avoid confusion

You've been selected! STAT+ for less than $2/day

Subscribe to STAT+ for less than $2 per day

Subscribe to STAT+ for less than $2 per day

Become a STAT+ subscriber today!